Панадол Экстра

Quick links

Choose a section

Quick links to important sections

Advertisements

Панадол Экстра

Advertisements
Advertisements

Overview of Панадол Экстра

Property Description
Active Ingredients Acetaminophen and Caffeine
Form Film-coated tablet (Oral dosage form)
Pharmacological Class Analgesic, Antipyretic, CNS Stimulant
Common Use Symptomatic pain and fever management
Origin Synthetic

Панадол Экстра is defined as a combined pharmacological agent intended for oral administration, primarily classified as a non-opioid analgesic and antipyretic. This medicinal entity is a synthetic combined preparation designed to manage pain and elevated body temperature. Unlike single-ingredient paracetamol formulations, the inclusion of an adjuvant substance defines its identity and synergistic action.

The preparation contains two key active ingredients: Acetaminophen (Paracetamol) and Caffeine. Both components are of synthetic origin. The Acetaminophen component provides the essential analgesic and antipyretic effects by influencing the central perception of pain and the body's temperature regulation. The second component, Caffeine, categorized as a Central Nervous System (CNS) stimulant, is included to exert an analgesic enhancement.

The addition of Caffeine to Acetaminophen can improve the rate and extent of the pain-relieving effect when compared to Acetaminophen alone. The formulation is intended for providing more effective symptomatic treatment in situations requiring enhanced relief, such as managing general body discomfort. The general purpose of this formulation is to leverage this synergistic action for the comprehensive management of pain and fever.

Regulatory References

  1. Definition of Analgesic
  2. Antipyretics (Paracetamol)
  3. Definition of Central Nervous System Stimulant
  4. Definition of Pain (NIH)
  5. Fever (MedlinePlus/NIH)
  6. Paracetamol Origin (NIH)
  7. Non-opioid Analgesic (NIH)
  8. Paracetamol (Acetaminophen) Information (NIH)
  9. Adjuvant (EMA)
  10. Drug Synergism (NIH)
  11. Prescription Stimulants (NIH/NIDA)
  12. Potentiation (NIH/NCI)
  13. Symptomatic Treatment (NIH)
Advertisements

What side effects are possible with Панадол Экстра?

Possible side effects and safety information

Official regulatory documentation organizes the medicine's potential risks into frequency categories and System-Organ Classes (SOC), based on data derived from clinical trials and post-marketing surveillance. This framework establishes the drug’s official safety profile.


Adverse Reactions by Frequency and System-Organ Class

The most commonly reported adverse effects are associated with the Central Nervous System Stimulant component, Caffeine, and are categorized as Common in regulatory documents. These typically affect the Psychiatric and Nervous System Disorders SOCs, including insomnia, nervousness, and dizziness. Effects on Cardiac Disorders, such as palpitations, may also occur.

Serious Adverse Reactions and Safety Constraints

The most critical risk documented is Severe Hepatotoxicity (liver damage) associated with the Acetaminophen component. This reaction is dose-dependent and can be fatal, prompting strict regulatory constraints. For this reason, the product is generally contraindicated in individuals with severe pre-existing Hepatic Impairment.

Very Rare but serious reactions affecting the Immune System Disorders include anaphylaxis and severe, sometimes life-threatening, Severe Cutaneous Adverse Reactions (SCARs), such as Stevens-Johnson Syndrome. Rare adverse effects on the Blood and Lymphatic System, such as thrombocytopenia, have also been documented.


Safety Considerations and Limitations

Official labeling contains explicit safety notes regarding dose-related patterns. The risk of severe liver damage is directly linked to exceeding the maximum recommended total daily dose of Acetaminophen. Furthermore, the label advises limiting the use of other caffeine-containing products while taking this medication to avoid excessive stimulation and associated adverse effects.

Advertisements

Overdose and Emergency Response

Overdose and when to seek help

The official regulatory profile for Панадол Экстра overdose describes a dual-component toxicity that mandates immediate emergency action. Early clinical signs are often non-specific, including nausea, vomiting, anorexia, and abdominal pain. Due to the Acetaminophen component, severe manifestations, such as acute liver failure and hepatic necrosis, may be delayed for several days, requiring medical assessment even if initial symptoms are mild or absent. Life-threatening outcomes, including acute renal failure, hepatic encephalopathy, and coma, are documented complications.

Overdose with the Caffeine component may contribute to Central Nervous System (CNS) effects such as tachycardia (rapid heartbeat), tremor, restlessness, or, in severe cases, seizures and cardiac arrhythmias.

When to Seek Immediate Medical Help: Government regulatory guidance requires that immediate medical attention must be sought for any suspected overdose or ingestion exceeding the maximum recommended dose, regardless of the individual’s apparent well-being. Contacting emergency services is necessary if a person collapses, has a seizure, or experiences difficulty breathing.

Management includes mandatory laboratory monitoring, such as measuring plasma paracetamol concentration. The existence of a specific antidote, N-acetylcysteine (NAC), is documented in the official label, and its prompt administration is crucial. Individuals with chronic alcohol use or pre-existing liver impairment are officially noted to be at increased risk of severe toxicity.

Advertisements

Therapeutic Uses of Панадол Экстра

The primary purpose of Панадол Экстра is to provide symptomatic relief for various conditions marked by symptoms related to physical discomfort and systemic imbalance, assisting patients in managing periods of heightened distress.

This combination is considered relevant for symptomatic support across conditions where additional management of discomfort is required. This agent is commonly used to help with symptomatic support across conditions presenting with localized or systemic discomfort, including headache, tension-type headache, migraine, acute toothache, backache, muscular aches, and period pain (dysmenorrhoea). It is also applied in settings marked by temporary physiological imbalance, specifically for reducing fever and easing the malaise associated with colds and flu.

This combination helps patients cope more steadily with symptom fluctuations. The medication provides support that helps ease the overall symptom burden.


Clinical Context: Episodic Pain This medication is commonly used when symptoms intensify during acute, episodic pain states, such as an acute toothache or a migraine attack, where supportive symptom management is appropriate.

Advertisements

Eligibility and Restrictions for Use

This section outlines the eligibility criteria for Panadol Extra (Paracetamol/Caffeine) based strictly on official regulatory documentation.


Contraindicated Populations

Use of this medicine is prohibited in individuals with a known hypersensitivity (allergy) to paracetamol, caffeine, or any of the product's ingredients. It must not be used concurrently with any other product containing paracetamol due to the risk of overdose, which can lead to serious liver damage.

Age-Related Eligibility

  • Children under 12 years of age are not recommended to use this medicine.
  • It is generally used by adults, including the elderly, and adolescents 12 years of age and over.

Condition-Specific Restrictions

Patients with certain health conditions must consult a doctor before use:

  • Liver Disease or Kidney Disease (impaired hepatic or renal function).
  • Chronic alcoholism or severe malnutrition, as these increase the risk of toxicity related to the paracetamol component.
  • Concurrent intake of excessive caffeine (from diet or other medicines) should be avoided.

Pregnancy and Lactation

Use of the paracetamol-caffeine combination is not recommended during pregnancy or breastfeeding.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information requires careful consideration of the following documented interaction patterns for Панадол Экстра (Acetaminophen/Caffeine).

Interaction Classifications

Classification Details
Prohibited Co-administration The product must not be taken with any other medicine containing paracetamol to prevent exceeding the recommended limit, which carries a risk of hepatotoxicity.
Anticoagulant Risk Repeated dosing for longer than one week can increase the effect of coumarin anticoagulants (e.g., warfarin), which may lead to bleeding.
Absorption Rate Modifiers The rate of absorption can be increased by Metoclopramide or Domperidone, and reduced by Colestyramine.
Hepatic Enzyme Interaction Caution is advised when taking with medicines that induce hepatic microsomal enzymes, such as phenobarbital, phenytoin, carbamazepine, or rifampicin.

Other Documented Substance Interactions

Official documents advise caution regarding co-ingestion with other hepatotoxic substances, including alcohol. Furthermore, the intake of caffeine-containing drinks (coffee, tea, cola) and other medicines containing caffeine should be limited to avoid excessive central nervous system stimulation. For Colestyramine, the official label specifies a timing restriction, stating it should not be taken within one hour of this medicine if maximum analgesic relief is required.

Advertisements

Mechanism of Action

Central Prostaglandin Synthesis Inhibition

Panadol Extra (Paracetamol/Acetaminophen) primarily acts within domains involving enzyme-mediated signaling in the central nervous system (CNS). Its core component modifies key molecular steps by inhibiting the synthesis of prostaglandins, specifically Prostaglandin E2 ( PGE2), in the brain and spinal cord. This mechanistic cascade is a key regulator of central thermoregulatory pathways, resulting in the modulation of the hypothalamic set point. Concurrently, this action contributes to the modulation of nociceptive pathway excitability at the central level, influencing the transmission of pain signals.


Augmentation of Nociceptive Modulation

The secondary component, caffeine, engages receptor-mediated signaling mechanisms, chiefly by acting as a non-selective antagonist of adenosine receptors in the CNS. This modulation of key pathways associated with neuronal activity alters the release of various neurotransmitters. This effect modifies central nervous system signaling, which increases the overall effect profile of the primary component. This interaction results in altered downstream signal transduction within nociceptive pathways and associated transmission systems.

Advertisements

Dosage and Administration Information

The use of Панадол Экстра is defined by official administration guidelines that dictate its precise dosage, route, and frequency. This combination preparation is supplied as a film-coated tablet and is authorized exclusively for oral administration, requiring the tablet to be swallowed whole with water. It may be taken with or without food. The standardized administration protocol establishes a maximum drug exposure limit and specifies time restrictions.


Labeled Dosing and Frequency

The usage pattern for adults and adolescents aged 12 years and older follows a time-constrained schedule. The typical single dose is 1 to 2 tablets, delivering 500 mg to 1000 mg of Acetaminophen and 65 mg to 130 mg of Caffeine. To maintain the official therapeutic window, a minimum interval of 4 hours must be observed between subsequent doses. The total intake must not exceed the maximum daily limit of 8 tablets within a 24-hour period. The product is not recommended for children under 12 years of age.

Use Parameter Official Guideline
Administration Route Oral (Swallow whole with water)
Max Single Dose 2 tablets
Max Daily Dose 8 tablets (4000 mg Acetaminophen)
Minimum Interval 4 hours
Duration of Use Short-term

This protocol is established for short-term symptomatic management, limiting application to brief periods. These official constraints ensure that the administration of the medicine strictly follows established requirements.

Advertisements

Recent Clinical Evidence

Recent Clinical Evidence: Paracetamol and Caffeine Combination

Efficacy in Acute Pain

Clinical trials were conducted to examine the combination of paracetamol (acetaminophen) and caffeine in managing various types of acute mild to moderate pain. Studies frequently assessed a combination dosage of 1,000 mg paracetamol and 130 mg caffeine against paracetamol alone and placebo.

  • Headache and Migraine: Multiple randomized controlled trials (RCTs) and systematic reviews have evaluated the combination for primary headaches, including episodic tension-type headaches and acute migraine attacks. Results consistently suggest that the addition of caffeine to paracetamol is associated with an increased likelihood of achieving substantial pain relief compared to paracetamol alone, particularly within the first few hours.
  • Other Acute Pain: Studies were also conducted in other acute pain states, such as postpartum pain and dental pain following extraction. These trials reported that the combination was linked to a greater proportion of participants achieving at least 50% maximum pain relief compared to the analgesic component used alone.

Safety and Tolerability

The safety profile of the paracetamol and caffeine combination has been investigated primarily in the context of short-term use for acute pain. Data from clinical trials generally indicate that the frequency of adverse events is similar to that of paracetamol alone, with most side effects reported as mild.

Commonly reported adverse events (likely due to the caffeine component) include symptoms such as nervousness, restlessness, and stomach discomfort, although these are typically infrequent.

Study Focus Measured Outcome Finding vs. Paracetamol Alone
Acute Pain Relief 50% Maximum Pain Relief Greater proportion of participants achieved outcome
Tolerability Adverse Event Frequency Generally similar across groups

Long-Term Research Gaps

Evidence remains limited concerning the comparative utility and safety profile of the combination in the long-term management of chronic pain conditions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Панадол Экстра (FAQ)

Q: Как быстро начинает действовать Панадол Экстра после приема?

A: Official documents state that the main ingredient, acetaminophen, is rapidly absorbed, typically reaching its highest concentration in the bloodstream within 0.5 to 2 hours. The inclusion of caffeine in this combination is described as helping to accelerate the rate of absorption, which is associated with a faster time to the onset of pain relief compared to paracetamol alone.


Q: Как долго длится эффект обезболивания от Панадол Экстра?

A: The effect duration is related to the time it takes for the components to be eliminated from the body. The half-life of paracetamol is typically 1 to 4 hours, and caffeine's half-life is slightly longer, at about 4 to 5 hours. The recommended minimum time interval between doses is 4 hours, which relates to the drug's presence in the body.


Q: Что делать, если пропустил время приема Панадол Экстра?

A: If a dose is missed, regulatory guidance generally advises skipping that dose and continuing with the next scheduled dose. It is essential to strictly maintain the minimum time interval of 4 hours between doses. Regulatory guidance prohibits doubling doses to make up for a missed one.


Q: Влияет ли Панадол Экстра на артериальное давление?

A: Official documents note that common adverse effects associated with the caffeine component include palpitations (an increased heart rate). In some individuals, the drug's label indicates that this stimulant action may be linked to a temporary or transient increase in blood pressure.


Q: Есть ли в официальных документах информация о привыкании к Панадол Экстра?

A: The primary analgesic ingredient, paracetamol, is not associated with dependency. However, official information notes that the caffeine component is a central nervous system stimulant, and habitual or excessive use of caffeine is associated with the potential for developing physical dependence and withdrawal symptoms.


Q: В чем разница между таблетками и растворимыми формами Панадол Экстра?

A: Official information indicates that soluble (effervescent) formulations often contain excipients, such as sodium bicarbonate. These components are often designed to accelerate the rate at which the active substance is absorbed, which is associated with a quicker time to onset of pain relief compared to standard tablets.


Q: Есть ли данные о влиянии Панадол Экстра на способность управлять автомобилем?

A: Official product information usually states that this medicine has no or negligible influence on the ability to drive or operate machinery. However, if an individual experiences side effects like dizziness or nervousness, the official label advises that activities requiring attention, such as driving or using machines, should be avoided.


Q: Если у меня гастрит, можно ли принимать Панадол Экстра?

A: Official regulatory documents indicate that patients with pre-existing gastrointestinal conditions, such as gastritis or stomach ulcers, may need to seek advice from a healthcare professional before use. Official labeling highlights that certain health conditions may require professional guidance regarding the product's use.


Q: Может ли Панадол Экстра вызывать сухость во рту?

A: Dry mouth is not listed as one of the most common side effects in official safety summaries. Nevertheless, some adverse event lists for combination analgesics do include dry mouth as a possible, though generally infrequent, side effect associated with use.


Q: Почему Панадол Экстра отпускается без рецепта?

A: The medicine is available over-the-counter (non-prescription) due to its regulatory classification. This classification is based on the established safety profile and composition at recommended doses, which is the regulatory standard for products intended for the self-management of minor pain and fever.


Q: Описана ли эффективность Панадол Экстра при менструальных болях?

A: The combination of acetaminophen and caffeine is officially indicated for the temporary relief of general minor aches and pains. This broad indication covers conditions like menstrual cramps, and similar combination products are specifically labeled for relieving menstrual discomfort.


Q: Может ли прием Панадол Экстра спровоцировать головную боль (феномен рикошета)?

A: Official safety considerations note that taking combination pain relievers, particularly those containing caffeine, too frequently or for prolonged periods can increase the risk of Medication Overuse Headaches (often called rebound headaches). The potential for this adverse event is one reason why the regulatory constraint for the medicine specifies short-term use for symptomatic relief.


Q: Можно ли принимать Панадол Экстра людям с сахарным диабетом?

A: Official drug interaction information notes that the caffeine component may potentially influence blood sugar levels. Official guidelines suggest that patients with diabetes may need to monitor their blood sugar levels more closely while using products containing caffeine.


Q: Можно ли принимать Панадол Экстра людям с бронхиальной астмой?

A: General medical guidance states that people with asthma can typically use acetaminophen-based medicines safely. However, official safety precautions indicate that if a worsening of asthma symptoms occurs after using the drug, a healthcare professional should be contacted.


Q: Какая информация о фармакокинетике Панадол Экстра содержится в официальных документах?

A: Official documents, such as the Summary of Product Characteristics (SmPC), contain a dedicated section on Pharmacokinetic Properties. This section details the technical information regarding how the body absorbs, distributes, metabolizes, and eliminates both the paracetamol and caffeine components, including their half-lives and time to peak concentration.


Q: Описывает ли инструкция к Панадол Экстра его взаимодействие с оральными контрацептивами?

A: Official interaction information sometimes notes that the estrogen component of certain oral contraceptives may increase the levels of caffeine in the bloodstream. This effect could potentially increase the likelihood or severity of experiencing side effects associated with the caffeine in the medicine.

Advertisements

How should Панадол Экстра be stored and disposed of?

The official storage conditions for Panadol Extra tablets are defined by regulatory agencies to maintain product stability. The medicine must be kept in the original pack in a cool, dry place, protected from excess heat and moisture [1.1, 2.1].

Storage temperature requirements specify keeping the product below 25 C or 30 C [1.2, 1.3]. It is explicitly stated that the product should not be stored in humid areas like bathrooms or near a sink, nor left in a car or on a window sill [1.1].

For safety, the product must be stored out of the sight and reach of children [1.1]. Unused or expired tablets must not be thrown away with household trash or flushed down the toilet. Disposal requires returning the medicine to a pharmacist or using an approved drug take-back program [1.2, 2.4].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Панадол Экстра found in:

A-Z Index: